Related Experiment Video
Updated: Jun 28, 2025
08:12
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.5K
MicroRNAs in hepatocellular carcinoma treatment: Charting the path forward
Hong T Lin1, Antonio F Alvarez Castaneda1, Somashekar G Krishna1
1Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
World Journal of Gastroenterology
|April 15, 2024
Summary
MicroRNAs (miRNAs) show promise for diagnosing and treating liver cancer (HCC). miRNA technology can target tumor microenvironments, potentially leading to better HCC therapies.
Area of Science:
- Molecular Biology
- Oncology
- Biotechnology
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression with significant implications for hepatocellular carcinoma (HCC) prognosis and treatment.
- Hepatocellular carcinoma development is influenced by its surrounding microenvironment, which contains both cancer-promoting and cancer-suppressing elements.
Discussion:
- miRNA technology, when delivered effectively, can directly interact with the tumor microenvironment.
- This interaction can inhibit the formation and progression of HCC tumors.
Key Insights:
- miRNAs offer a novel therapeutic strategy for HCC by targeting the tumor microenvironment.
- The precise mechanisms by which miRNAs modulate oncogenic and tumor-suppressive elements in HCC require further elucidation.
Outlook:
- Continued research into miRNA delivery systems and their interactions within the tumor microenvironment is crucial.
- miRNA-based therapies hold the potential to significantly advance multi-modal treatment strategies for HCC.
